OTCMKTS:POLXF Polydex Pharmaceuticals (POLXF) Stock Price, News & Analysis → Biden to Launch “FedNOW” [Move Your Money Now] (From Priority Gold) (Ad) Free POLXF Stock Alerts $1.99 +0.01 (+0.30%) (As of 08/7/2023) Add Compare Share Share Today's Range$1.99▼$1.9950-Day Range$1.99▼$1.9952-Week Range$0.55▼$2.01Volume2,000 shsAverage VolumeN/AMarket Capitalization$6.81 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisEarningsStock AnalysisEarnings Get Polydex Pharmaceuticals alerts: Email Address Ad Stansberry ResearchGold ManiaFormer Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite).See his free reveal right here. About Polydex Pharmaceuticals Stock (OTCMKTS:POLXF)Polydex Pharmaceuticals Ltd. is a development stage company, which engages in manufacturing of bulk pharmaceutical intermediates for the worldwide veterinary pharmaceutical industry, and the development, manufacturing, and marketing of biotechnology-based products for the human pharmaceutical market. The firm focuses on Dextran and derivative products, including Iron Dextran and Dextran Sulphate and other specialty chemicals. The company was founded by Thomas C. Usher on June 14, 1979 and is headquartered in Toronto, Canada.Read More POLXF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart POLXF Stock News HeadlinesMay 3, 2024 | americanbankingnews.comPolydex Pharmaceuticals (OTCMKTS:POLXF) Shares Cross Below Two Hundred Day Moving Average of $1.99July 18, 2023 | finance.yahoo.comPolydex Pharmaceuticals Limited Shareholders Vote to Approve BioSpectra Inc. Business CombinationMay 3, 2024 | Altimetry (Ad)Urgent Nvidia WarningCould Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.June 15, 2023 | finanznachrichten.dePolydex Pharmaceuticals Limited: Polydex Pharmaceuticals Issues First Quarter Financial ResultsApril 27, 2023 | finance.yahoo.comPolydex Pharmaceuticals Limited and BioSpectra Inc. Announce Business CombinationApril 18, 2023 | barrons.comPolydex Pharmaceuticals Ltd.September 17, 2022 | seekingalpha.comPolydex Pharmaceuticals GAAP EPS of -$0.09, revenue of $1.09MSeptember 16, 2022 | nz.finance.yahoo.comGlobal Computed Tomography (CT) Scanner Market to Reach $9.38 Billion by 2028 | Demand for AI based CT Scanner is On the RiseMay 3, 2024 | Altimetry (Ad)Urgent Nvidia WarningCould Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.August 24, 2022 | reuters.comPolydex Pharmaceuticals LtdAugust 13, 2022 | finance.yahoo.comPolydex Pharmaceuticals Limited (POLXF)June 17, 2022 | seekingalpha.comPolydex Pharmaceuticals GAAP EPS of -$0.02, revenue of $1.15MMay 4, 2022 | nz.finance.yahoo.comMarshall Plan for Moms Mother's Day Mission: Cure Chronic Mom GuiltMay 3, 2022 | nz.finance.yahoo.comQED Investors Hires Victoria Zuo to Help Scale Early Stage TeamMay 3, 2022 | yahoo.comTaste: Protein shakes are a great tool to meet macro goalsJanuary 29, 2022 | nasdaq.comPolydex Pharmaceuticals Inc (POLXF)January 26, 2022 | finance.yahoo.comPolydex Pharmaceuticals Announces Collaboration with Termanox Water Treatment Solutions for novel use of Native DextranJanuary 5, 2022 | investing.comPolydex Pharmaceuticals Ltd (POLXF)December 17, 2021 | nz.finance.yahoo.comGlobal Plastic Recycling Market Witnessing an Upward Growth Trajectory—Projected to Reach USD 71.5 Billion by 2027 | BlueWeaveSeptember 16, 2021 | nz.finance.yahoo.comTP-Link Reveals Flagship Archer AX6600 Tri-Band Wi-Fi 6 Gaming Router for just $249.99See More Headlines Receive POLXF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Polydex Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/03/2024Fiscal Year End1/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Industrial inorganic chemicals Sub-IndustryN/A Current SymbolOTCMKTS:POLXF CUSIPN/A CIK317158 Webwww.polydex.com Phone(416) 755-2231FaxN/AEmployees20Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$4.41 million Price / Sales1.54 Cash FlowN/A Price / Cash FlowN/A Book Value$1.48 per share Price / Book1.34Miscellaneous Outstanding Shares3,430,000Free Float2,989,000Market Cap$6.81 million OptionableNot Optionable BetaN/A Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesGeorge G. UsherChairman, President & Chief Executive OfficerSharon L. WardlawChief Operating Officer, Secretary & TreasurerDavid P. M. JamesteeChief Financial OfficerLinda C. HughesHead-Media & Public RelationsKey CompetitorsShuttle PharmaceuticalsNASDAQ:SHPHEnveric BiosciencesNASDAQ:ENVBOrtho Regenerative TechnologiesOTCMKTS:ORTIFCalidi BiotherapeuticsNYSEAMERICAN:CLDITFF PharmaceuticalsNASDAQ:TFFPView All Competitors POLXF Stock Analysis - Frequently Asked Questions How have POLXF shares performed in 2024? Polydex Pharmaceuticals' stock was trading at $1.9860 at the beginning of the year. Since then, POLXF shares have increased by 0.0% and is now trading at $1.9860. View the best growth stocks for 2024 here. How do I buy shares of Polydex Pharmaceuticals? Shares of POLXF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:POLXF) was last updated on 5/3/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldUrgent Nvidia WarningAltimetryAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldGold ManiaStansberry ResearchThe Gold Grab of the CenturyColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Polydex Pharmaceuticals Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
